Natalie Homer

Dr. Natalie Homer

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Ophthalmic Plastic & Reconstructive Surgery
Verified
Journal Article
Closed access
NHNatalie Homer
Natalie Homer
APAnika S. Patel
Anika S. Patel
AEAliza Epstein
Aliza Epstein
VDVikram D. M.D. Durairaj
Vikram D. M.D. Durairaj
TNTanuj M.D. Nakra
Tanuj M.D. Nakra
Purpose: Autologous fat transfer is an effective tool for volume restoration to the aging face. Although numerous reports exist regarding injection site complications, there is limited data on donor-site morbidity in the cosmetic surgery literature. Methods: This study is a large-scale retrospective review to determine incidence of fat harvest-site complications, identify risk factors, and describe management strategies. Records of all patients who underwent autologous fat harvesting and facial grafting at a single oculofacial plastic surgery practice from 2010 to 2019 were reviewed. Patient demographics and clinical data were collected and assessed. A statistical analysis was performed using a two-tailed T-test with p values of <0.05 considered significant. Results: Four-hundred sixteen patients were followed for an average of 6.2 months postoperatively. There was an overall 5.5% harvest-site complication rate. There was no correlation of harvest-site complications with gender (p = 0.249) or age (p = 0.881). Harvest location did not significantly correlate with complication rate. The most common complications were contour irregularities, prolonged induration, and prolonged erythema. Low body mass index was associated with higher complication rate (p = 0.003), even when excluding those patients with contour irregularities (p = 0.001). Various treatment modalities were used to manage donor-site morbidity with consistent improvement. Conclusions: Autologous fat transfer used for facial volume augmentation has low donor-site morbidity. Minor harvest-site complications occur more commonly in patients with low body mass index, irrespective of age, gender, or fat source.

17 May 2021 in Ophthalmic Plastic & Reconstructive Surgery
Verified
Journal Article
Closed access
NHNatalie Homer
Natalie Homer
SZSiwei Zhou
Siwei Zhou
AWAlison H. Watson
Alison H. Watson
VDVikram D. Durairaj
Vikram D. Durairaj
TNTanuj Nakra
Tanuj Nakra
Purpose: There have been limited studies evaluating specifically the incidence of wound dehiscence following isolated upper blepharoplasty. This is a large-scale upper blepharoplasty review to evaluate the rate of wound dehiscence, to assess risk factors, and to analyze management outcomes. Methods: A retrospective review was performed of all patients who underwent upper blepharoplasty at a single surgery center. All incisions were closed using either 6-0 fast-absorbing plain gut or polypropylene suture in a running fashion, with an additional interrupted suture near the lateral wound edge. Incidence of wound dehiscence was determined and further assessed by patient age (<= 67 or >67 years), gender, preexisting medical conditions, smoking history, and suture type. Results: A total of 1,190 patients (2,376 eyelids) met inclusion criteria. In total, there were 34 instances (1.4%) of wound dehiscence in 32 patients at an average 9 days (range, 0-30 days) following surgery. Evaluation of wound dehiscence rates by demographic factors revealed male gender to be a significant predictor of wound dehiscence (p = 0.0062). Age, hypertension, heart disease, and diabetes were not predictors of wound dehiscence. Lifetime smoking history increased risk for wound dehiscence (p < 0.0001). Use of fast-absorbing plain gut suture was also significantly associated with dehiscence, when compared with polypropylene (p = 0.0025). Multivariate analysis revealed male gender and fast-absorbing plain gut suture to be independent risk factors for wound dehiscence. Seventeen eyelids with wound separation were observed for second-intention healing, 1 underwent delayed scar revision. Fourteen eyelids were repaired primarily using suture and 3 with cyanoacrylate surgical skin adhesive. All patients reported satisfaction with their final outcome, and objective final healing was deemed satisfactory. Conclusions: Wound dehiscence following isolated upper blepharoplasty is rare and associated with male gender and fast-absorbing plain gut suture. Patients with wound separation may be successfully managed with individualized care.

1 August 2024 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
AVAshtyn Z. Vogt
Ashtyn Z. Vogt
PKPouriska B. Kivanany
Pouriska B. Kivanany
MNMatthew A. De Niear
Matthew A. De Niear
IVIvan M. Vrcek
Ivan M. Vrcek
NHNatalie Homer
Natalie Homer
Background: Tranexamic acid has been increasingly used in facial plastic surgery to improve perioperative hemostasis. While subcutaneous tranexamic acid has been found to not significantly decrease postoperative ecchymoses following upper blepharoplasty, systemic administration has not previously been studied. Methods: A total of 325 patients undergoing upper blepharoplasty were randomly assigned to either receive intravenous tranexamic acid or serve as a control. Patients in the experimental group were administered 1 g of tranexamic acid intravenously 10 minutes before surgical incision. A similar upper blepharoplasty technique was performed by two American Society of Ophthalmic Plastic and Reconstructive Surgery-trained surgeons. Follow-up was conducted at a median of 8 days postsurgery. Patient photographs were evaluated by two independent graders to rate ecchymoses on a scale of 0 (least) to 10 (most). Results: Of the 325 included patients, 138 patients received intravenous tranexamic acid and 187 patients did not. The average ecchymosis rating for the control group at day 8 was 5.8 ± 1.7, while the average rating for the tranexamic acid group at the same time point was 4.1 ± 1.6 (P < 0.0001). There was a trend toward decreased ecchymoses in the tranexamic acid group at earlier and later postoperative timepoints that did not reach statistical significance. No hemorrhagic or systemic embolic complications occurred. Conclusions: Systemic tranexamic acid may reduce postoperative ecchymoses after upper blepharoplasty surgery, reaching significance at the eighth postoperative day, which may lead to improved patient satisfaction and decreased occupational downtime.

29 October 2020 in Orbit
Verified
Journal Article
Closed access
NHNatalie Homer
Natalie Homer
AEAliza Epstein
Aliza Epstein
MSMarie Somogyi
Marie Somogyi
JSJohn W. Shore
John W. Shore
In March 2020, the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) advised the suspension of all non-emergent oculofacial patient care, imparting unprecedented interrupti...

3 March 2021 in Orbit
Verified
Journal Article
Closed access
DSDarsh S. Shah
Darsh S. Shah
NHNatalie Homer
Natalie Homer
AEAliza Epstein
Aliza Epstein
VDVikram D. Durairaj
Vikram D. Durairaj
Mantle cell lymphoma is a rare malignancy to present in the orbit, comprising only 1–5% adnexal lymphomas. Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is an equally uncommon adnexal tumor of sweat gland origin that may present on the eyelid. Herein we present a case of a 77-year old man with no previous cancer history who presented with painless progressive left globe proptosis and an enlarging left upper lid margin lesion, ultimately determined upon biopsy to be simultaneous orbital mantle cell lymphoma with systemic involvement and isolated eyelid EMPSGC. The pathogenesis, clinical manifestation, and management for each rare disease entity are reviewed and concept of collision tumors is discussed.

2 January 2021 in Orbit
Verified
Journal Article
Closed access
NHNatalie Homer
Natalie Homer
PHPaul M. Hoesly
Paul M. Hoesly
VDVikram D. Durairaj
Vikram D. Durairaj
(2020). Atypical presentation of an endocrine mucin-producing sweat gland carcinoma of the eyelid. Orbit. Ahead of Print.